1 – 50 of 107
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS) : comparison with multiple myeloma
2019) In Leukemia(
- Contribution to journal › Letter
-
Mark
Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance
(
- Contribution to journal › Letter
- 2018
-
Mark
Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6 dependent manner
(
- Contribution to journal › Article
- 2017
-
Mark
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors : a multicenter IMWG study
(
- Contribution to journal › Article
- 2016
-
Mark
Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.
(
- Contribution to journal › Article
-
Mark
Genetic factors influencing the risk of multiple myeloma bone disease.
(
- Contribution to journal › Article
-
Mark
Management of relapsed multiple myeloma: Recommendations of the international myeloma working group.
(
- Contribution to journal › Scientific review
-
Mark
Search for familial clustering of multiple myeloma with any cancer.
(
- Contribution to journal › Article
-
Mark
Familial associations of monoclonal gammopathy of unknown significance with autoimmune diseases
(
- Contribution to journal › Letter
- 2015
-
Mark
IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome.
(
- Contribution to journal › Article
-
Mark
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.
(
- Contribution to journal › Scientific review
-
Mark
Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women - a Swedish Lymphoma Registry study.
(
- Contribution to journal › Article
-
Mark
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real time quantitative PCR.
(
- Contribution to journal › Article
-
Mark
TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement.
(
- Contribution to journal › Article
-
Mark
The DEK oncoprotein and its emerging roles in gene regulation.
(
- Contribution to journal › Scientific review
-
Mark
Loss of HIF-1α accelerates murine FLT-3ITD-induced myeloproliferative neoplasia.
(
- Contribution to journal › Article
-
Mark
Cellular origin of prognostic chromosomal aberrations in AML patients.
(
- Contribution to journal › Letter
-
Mark
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.
(
- Contribution to journal › Letter
-
Mark
Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
(
- Contribution to journal › Article
-
Mark
Disruption of the 5S RNP-Mdm2 interaction significantly improves the erythroid defect in a mouse model for Diamond-Blackfan anemia.
(
- Contribution to journal › Article
-
Mark
Total body irradiation after high-dose cytarabine in mantle cell lymphoma: A comparison of Nordic MCL2, HOVON-45, and European MCLYounger trials.
2015) In Leukemia(
- Contribution to journal › Article
-
Mark
A novel Lin-CD34+CD38-integrin α2- bipotential megakaryocyte-erythrocyte progenitor population in human bone marrow.
(
- Contribution to journal › Article
- 2014
-
Mark
Detecting dic(9;20)(p13.2;p11.2)-positive B-cell precursor acute lymphoblastic leukemia in a clinical setting using fluorescence in situ hybridization
(
- Contribution to journal › Letter
-
Mark
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
(
- Contribution to journal › Scientific review
-
Mark
On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort
(
- Contribution to journal › Letter
-
Mark
Inherited genetic susceptibility to multiple myeloma
(
- Contribution to journal › Scientific review
-
Mark
Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia
(
- Contribution to journal › Letter
-
Mark
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma.
(
- Contribution to journal › Scientific review
-
Mark
RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.
(
- Contribution to journal › Letter
-
Mark
Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans.
(
- Contribution to journal › Letter
-
Mark
Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.
(
- Contribution to journal › Article
-
Mark
Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma.
(
- Contribution to journal › Letter
- 2013
-
Mark
Whole-genome-amplified DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acute myeloid leukemia
(
- Contribution to journal › Letter
-
Mark
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
(
- Contribution to journal › Letter
-
Mark
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia
(
- Contribution to journal › Letter
-
Mark
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
(
- Contribution to journal › Article
-
Mark
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
(
- Contribution to journal › Article
-
Mark
Partial 17q gain resulting from isochromosomes, unbalanced translocations, and complex rearrangements is associated with gene overexpression, older age, and shorter overall survival in high hyperdiploid childhood acute lymphoblastic leukemia.
(
- Contribution to journal › Letter
-
Mark
Distinct patterns of gained chromosomes in high hyperdiploid acute lymphoblastic leukemia with t(1;19)(q23;p13), t(9;22)(q34;q22) or MLL rearrangements.
(
- Contribution to journal › Letter
-
Mark
Loss of chromosomes is the primary event in near-haploid and low hypodiploid acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
(
- Contribution to journal › Article
- 2012
-
Mark
SPARC is dispensable for murine hematopoiesis, despite its suspected pathophysiological role in 5q- myelodysplastic syndrome.
(
- Contribution to journal › Article
-
Mark
Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.
(
- Contribution to journal › Article
-
Mark
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT
(
- Contribution to journal › Article
-
Mark
Coexistence of trisomies of chromosomes 12 and 19 in chronic lymphocytic leukemia occurs exclusively in the rare IgG-positive variant
(
- Contribution to journal › Letter
-
Mark
Whole-exome sequencing of pediatric acute lymphoblastic leukemia.
(
- Contribution to journal › Article
- 2011
-
Mark
Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications
(
- Contribution to journal › Scientific review
-
Mark
The role of Smad signaling in hematopoiesis and translational hematology.
(
- Contribution to journal › Article
-
Mark
The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial
(
- Contribution to journal › Article